Daniel Heudobler Selected Research

Daniel Heudobler Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 01/2018
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 01/2018
4	Inflammation (Inflammations) 12/2023 - 09/2012
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2018
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2023 - 12/2022
2	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 01/2021
2	Pathologic Complete Response 01/2022 - 01/2020
2	Infections 02/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2021
2	Poisoning 11/2018 - 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2024
1	Melanoma (Melanoma, Malignant) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Acute Promyelocytic Leukemia 01/2022
1	Residual Neoplasm 12/2021
1	COVID-19 11/2021
1	Viremia 02/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Myasthenia Gravis 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Liver Failure 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Hemorrhage 01/2020
1	Venous Thromboembolism 01/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Anemia 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Hematologic Diseases (Blood Diseases) 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2015

Drug/Important Bio-Agent (IBA)

3	Azacitidine (5 Azacytidine)FDA Link 10/2023 - 01/2018
3	Pioglitazone (Actos)FDA Link 10/2023 - 01/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2021
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2023 - 01/2023
2	LigandsIBA 01/2023 - 04/2018
2	Drug CombinationsIBA 01/2022 - 01/2018
2	Immunomodulating AgentsIBA 11/2018 - 01/2018
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2018 - 01/2018
1	Cytostatic AgentsIBA 12/2023
1	claudin 6IBA 11/2023
1	AntigensIBA 11/2023
1	Chimeric Antigen ReceptorsIBA 11/2023
1	mRNA VaccinesIBA 11/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023
1	Everolimus FDA Link 01/2023
1	InterferonsIBA 01/2023
1	teleocalcinIBA 12/2021
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 11/2021
1	SteroidsIBA 02/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2021
1	NivolumabIBA 01/2021
1	treosulfanIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	PlatinumIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	RivaroxabanIBA 01/2020
1	apixabanIBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	ProteomeIBA 01/2019
1	hydrogen sulfite (bisulfite)IBA 01/2019
1	ThiazolidinedionesIBA 11/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2018
1	68Ga-pentixaforIBA 04/2018
1	UbiquitinIBA 04/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018
1	CholesterolIBA 09/2012

Therapy/Procedure

18	Therapeutics 01/2024 - 01/2018
12	Drug Therapy (Chemotherapy) 12/2023 - 01/2018
2	Induction Chemotherapy 10/2023 - 01/2021
2	Hematopoietic Stem Cell Transplantation 01/2020 - 11/2015
1	Precision Medicine 12/2023
1	Immunomodulation 12/2023
1	Combined Modality Therapy 01/2021
1	Withholding Treatment 01/2020
1	Palliative Care (Palliative Therapy) 11/2018